Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01707836 · ClinicalTrials.gov registry record
Neurofibromatosis Type 1 Brain Tumor Genetic Risk
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 176
- Enrollment target
NCT01707836: Completed study, sponsored by Washington University School of Medicine.
NCT01707836 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 176 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01707836 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 176 participants
- Enrollment target
Study Summary
This study will analyze DNA samples to determine associations between maternal and offspring genetic factors and pediatric brain tumor development in children with Neurofibromatosis Type 1. Participating families (mother, father, child) will be asked to complete a short questionnaire and provide DNA samples (either saliva or blood). The information gained from your participation may one day help doctors develop strategies to reduce brain tumor risk in individuals with NF1. Please note: there is no therapy associated with this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2012-10 |
| Est. Completion | 2017-05-08 |
What the finished NCT01707836 record still lists
NCT01707836 is an observational study that tracks outcomes without assigning an intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01707836 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01707836 about?
NCT01707836 is a clinical study titled "Neurofibromatosis Type 1 Brain Tumor Genetic Risk". This study will analyze DNA samples to determine associations between maternal and offspring genetic factors and pediatric brain tumor development in children with Neurofibromatosis Type 1. Participating families (mother, father, child) will be asked to complete a short questionnaire and provide DNA...
What is the current status of trial NCT01707836?
This trial is currently completed. The enrollment target is 176 participants. The study started on 2012-10. Estimated completion is 2017-05-08.
Who is sponsoring clinical trial NCT01707836?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03304821 · 176 participants · Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- NCT03447938 · 176 participants · NA
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- NCT03824145 · 176 participants · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- NCT04177914 · 176 participants · Phase 3
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia